QT
EDIT icon

Quantamental Technologies’s Editas Medicine EDIT Stock Holding History

Quantamental Technologies’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26,796
Closed -$328K – 512
2022
Q3 		$328K Buy
+26,796
New +$418K 0.13% 280
2019
Q3 		– Sell
-1,811
Closed -$45K – 1594
2019
Q2 		$45K Buy
+1,811
New +$43.2K 0.02% 927

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Quantamental Technologies's EDIT Position: Q4 2022 in Review

Quantamental Technologies sold out of Editas Medicine (EDIT) in Q4 2022, closing a stake of 26,796 shares — an estimated $328K sold.

Quantamental Technologies first reported a position in EDIT in Q2 2019 and held it in 2 quarters. The position peaked at $328K in Q3 2022. 250 funds tracked by Wall St. Rank hold EDIT as of Q4 2022.

  • Quantamental Technologies reported no remaining Editas Medicine position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 26,796 Editas Medicine shares in Q4 2022, an estimated $328K.
  • Quantamental Technologies first reported a position in Editas Medicine in Q2 2019 and held it in 2 quarters.
  • Quantamental Technologies's Editas Medicine position peaked at $328K in Q3 2022.
  • 250 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.